Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The Double-Trunk Mask Improves Oxygenation During High-Flow Nasal Cannula Therapy for Acute Hypoxemic Respiratory Failure.

Duprez F, Bruyneel A, Machayekhi S, Droguet M, Bouckaert Y, Brimioulle S, Cuvelier G, Reychler G.

Respir Care. 2019 Apr 30. pii: respcare.06520. doi: 10.4187/respcare.06520. [Epub ahead of print]

PMID:
31040207
2.

A New Formula for Predicting the Fraction of Delivered Oxygen During Low-Flow Oxygen Therapy.

Duprez F, Mashayekhi S, Cuvelier G, Legrand A, Reychler G.

Respir Care. 2018 Dec;63(12):1528-1534. doi: 10.4187/respcare.06243.

PMID:
30467224
3.

Effects of radiation on the metastatic process.

Sundahl N, Duprez F, Ost P, De Neve W, Mareel M.

Mol Med. 2018 Apr 24;24(1):16. doi: 10.1186/s10020-018-0015-8. Review.

4.

Radiochemotherapy-induced reactivation of scar tissue on 18F-FDG PET/CT.

Van Damme A, Duprez F, Tomassen P, Creytens D, Goethals I.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2229-2230. doi: 10.1007/s00259-018-4126-9. Epub 2018 Aug 11. No abstract available.

PMID:
30099577
5.

In Regard to Maguire et al.

Nevens D, Duprez F, Daisne JF, De Neve W, Nuyts S.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):746-747. doi: 10.1016/j.ijrobp.2018.03.031. No abstract available.

PMID:
29893287
6.

Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.

De Meulenaere A, Vermassen T, Creytens D, Aspeslagh S, Deron P, Duprez F, Rottey S, Van Dorpe JA, Ferdinande L.

Histopathology. 2018 Sep;73(3):500-509. doi: 10.1111/his.13650. Epub 2018 Jul 4.

PMID:
29768723
7.

Clinical factors impacting on late dysphagia following radiotherapy in patients with head and neck cancer.

Deschuymer S, Nevens D, Duprez F, Laenen A, Dejaeger E, De Neve W, Goeleven A, Nuyts S.

Br J Radiol. 2018 Jul;91(1088):20180155. doi: 10.1259/bjr.20180155. Epub 2018 May 23.

PMID:
29668302
8.

A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory.

Schatteman J, Van Gestel D, Berwouts D, De Gersem W, De Kerf G, De Neve W, De Ost B, Olteanu AML, Rottey S, Vercauteren T, Goethals I, Duprez F.

Strahlenther Onkol. 2018 Aug;194(8):727-736. doi: 10.1007/s00066-018-1293-3. Epub 2018 Mar 19.

PMID:
29556677
9.

Correlation of Patient- and Physician-Scored Dysphagia with Videofluoroscopies in Patients Treated with Radiotherapy for Head and Neck Cancer.

Nevens D, Goeleven A, Duprez F, Laenen A, Dejaeger E, De Neve W, Nuyts S.

Dysphagia. 2018 Oct;33(5):684-690. doi: 10.1007/s00455-018-9888-5. Epub 2018 Mar 3.

PMID:
29502135
10.

In Regard to Bibault et al.

Daisne JF, Nuyts S, Duprez F, Bihin B.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):807-808. doi: 10.1016/j.ijrobp.2017.11.039. No abstract available.

PMID:
29413296
11.

Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Reply to Elicin et al.

Nevens D, Duprez F, Bonte K, Deron P, Huvenne W, Laenen A, De Neve W, Nuyts S.

Radiother Oncol. 2018 Mar;126(3):571-572. doi: 10.1016/j.radonc.2017.12.015. Epub 2018 Jan 4. No abstract available.

PMID:
29307729
12.

Does the total dysphagia risk score correlate with swallowing function examined by videofluoroscopy?

Nevens D, Goeleven A, Duprez F, Braeken R, Decabooter E, De Smet M, Lutters L, Dejaeger E, De Neve W, Nuyts S.

Br J Radiol. 2018 Feb;91(1083):20170714. doi: 10.1259/bjr.20170714. Epub 2018 Jan 2.

13.

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer.

De Meulenaere A, Vermassen T, Aspeslagh S, Deron P, Duprez F, Laukens D, Van Dorpe J, Ferdinande L, Rottey S.

Oncotarget. 2017 Jul 6;8(46):80443-80452. doi: 10.18632/oncotarget.19045. eCollection 2017 Oct 6.

14.

Accuracy of Oxygen Flow Delivered by Compressed-Gas Cylinders in Hospital and Prehospital Emergency Care.

Duprez F, Michotte JB, Cuvelier G, Legrand A, Mashayekhi S, Reychler G.

Respir Care. 2018 Mar;63(3):332-338. doi: 10.4187/respcare.05657. Epub 2017 Oct 17.

15.

Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer.

Olteanu LAM, Duprez F, De Neve W, Berwouts D, Vercauteren T, Bauters W, Deron P, Huvenne W, Bonte K, Goethals I, Schatteman J, De Gersem W.

Acta Oncol. 2018 Feb;57(2):262-268. doi: 10.1080/0284186X.2017.1364867. Epub 2017 Sep 8.

PMID:
28885076
16.

Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.

Berwouts D, Madani I, Duprez F, Olteanu AL, Vercauteren T, Boterberg T, Deron P, Bonte K, Huvenne W, De Neve W, Goethals I.

Head Neck. 2017 Nov;39(11):2264-2275. doi: 10.1002/hed.24892. Epub 2017 Aug 21.

PMID:
28833829
17.

Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.

Nevens D, Duprez F, Bonte K, Deron P, Huvenne W, Laenen A, De Neve W, Nuyts S.

Radiother Oncol. 2017 Aug;124(2):220-224. doi: 10.1016/j.radonc.2017.07.011. Epub 2017 Jul 26.

PMID:
28756006
18.

Dose de-escalation to the elective lymph nodes in head and neck cancer. Reply to Amdur et al.

Nevens D, Duprez F, Daisne JF, De Neve W, Nuyts S.

Radiother Oncol. 2017 Aug;124(2):336. doi: 10.1016/j.radonc.2017.07.003. Epub 2017 Jul 24. No abstract available.

PMID:
28751230
19.

Distant metastases in head and neck cancer.

Duprez F, Berwouts D, De Neve W, Bonte K, Boterberg T, Deron P, Huvenne W, Rottey S, Mareel M.

Head Neck. 2017 Sep;39(9):1733-1743. doi: 10.1002/hed.24687. Epub 2017 Jun 26.

PMID:
28650113
20.

Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.

De Meulenaere A, Vermassen T, Aspeslagh S, Zwaenepoel K, Deron P, Duprez F, Rottey S, Ferdinande L.

Pathology. 2017 Jun;49(4):397-404. doi: 10.1016/j.pathol.2017.02.002. Epub 2017 Apr 17.

PMID:
28427753
21.

Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer.

Nevens D, Duprez F, Daisne JF, Schatteman J, Van der Vorst A, De Neve W, Nuyts S.

Radiother Oncol. 2017 Jun;123(3):419-423. doi: 10.1016/j.radonc.2017.03.003. Epub 2017 Mar 22.

PMID:
28342647
22.

Prognostic value of the seventh AJCC/UICC TNM classification of intestinal-type ethmoid adenocarcinoma: Systematic review and risk prediction model.

Fiaux-Camous D, Chevret S, Oker N, Turri-Zanoni M, Lombardi D, Choussy O, Duprez F, Jorissen M, de Gabory L, Malard O, Herman P, Nicolai P, Castelnuovo P, Verillaud B.

Head Neck. 2017 Apr;39(4):668-678. doi: 10.1002/hed.24663. Epub 2017 Jan 9. Review.

PMID:
28067974
23.

Radiotherapy induced dermatitis is a strong predictor for late fibrosis in head and neck cancer. The development of a predictive model for late fibrosis.

Nevens D, Duprez F, Daisne JF, Laenen A, De Neve W, Nuyts S.

Radiother Oncol. 2017 Feb;122(2):212-216. doi: 10.1016/j.radonc.2016.08.013. Epub 2016 Sep 20.

PMID:
27663951
24.

Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.

Nevens D, Duprez F, Daisne JF, Dok R, Belmans A, Voordeckers M, Van den Weyngaert D, De Neve W, Nuyts S.

Radiother Oncol. 2017 Feb;122(2):171-177. doi: 10.1016/j.radonc.2016.08.009. Epub 2016 Aug 12.

PMID:
27528118
25.

CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck.

De Meulenaere A, Vermassen T, Aspeslagh S, Zwaenepoel K, Deron P, Duprez F, Ferdinande L, Rottey S.

Pathobiology. 2016;83(6):327-33. doi: 10.1159/000446569. Epub 2016 Jul 8.

26.

Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.

Berwouts D, Olteanu LA, Speleers B, Duprez F, Madani I, Vercauteren T, De Neve W, De Gersem W.

Radiat Oncol. 2016 Apr 2;11:52. doi: 10.1186/s13014-016-0629-3.

27.

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.

Pottel L, Lycke M, Boterberg T, Pottel H, Goethals L, Duprez F, Rottey S, Lievens Y, Van Den Noortgate N, Geldhof K, Buyse V, Kargar-Samani K, Ghekiere V, Debruyne PR.

BMC Cancer. 2015 Nov 9;15:875. doi: 10.1186/s12885-015-1800-1.

28.

Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme.

Nevens D, Deschuymer S, Langendijk JA, Daisne JF, Duprez F, De Neve W, Nuyts S.

Radiother Oncol. 2016 Feb;118(2):293-7. doi: 10.1016/j.radonc.2015.10.008. Epub 2015 Oct 20.

PMID:
26477396
29.

Secondary Voice Restoration After Laryngotracheal Separation (LTS) for Dysphagia with Intractable Aspiration.

Bonte K, Huvenne W, De Loof M, Deron P, Viaene A, Duprez F, Vermeersch H.

Dysphagia. 2015 Dec;30(6):695-701. doi: 10.1007/s00455-015-9646-x. Epub 2015 Aug 12.

PMID:
26264593
30.

Morphometric Atlas Selection for Automatic Brachial Plexus Segmentation.

Van de Velde J, Wouters J, Vercauteren T, De Gersem W, Duprez F, De Neve W, Van Hoof T.

Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):691-8. doi: 10.1016/j.ijrobp.2015.02.045. Epub 2015 May 5.

PMID:
25956831
31.

Intensity-modulated radiotherapy for early-stage glottic cancer.

Berwouts D, Swimberghe M, Duprez F, Boterberg T, Bonte K, Deron P, De Gersem W, De Neve W, Madani I.

Head Neck. 2016 Apr;38 Suppl 1:E179-84. doi: 10.1002/hed.23967. Epub 2015 Jun 18.

PMID:
25537856
32.

Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial.

Pottel L, Lycke M, Boterberg T, Pottel H, Goethals L, Duprez F, Maes A, Goemaere S, Rottey S, Foubert I, Debruyne PR.

BMC Complement Altern Med. 2014 Oct 7;14:382. doi: 10.1186/1472-6882-14-382.

33.

A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.

De Ruyck K, Duprez F, Ferdinande L, Mbah C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel EJ, Libbrecht L, De Neve W, Lambin P, Thierens H.

Cancer Epidemiol. 2014 Oct;38(5):591-8. doi: 10.1016/j.canep.2014.07.008. Epub 2014 Aug 12.

PMID:
25127693
34.

High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.

Duprez F, Berwouts D, Madani I, Bonte K, Boterberg T, De Gersem W, Deron P, Huvenne W, De Neve W.

Radiother Oncol. 2014 Jun;111(3):388-92. doi: 10.1016/j.radonc.2014.04.018. Epub 2014 Jul 3.

PMID:
24998706
35.

HPV-related oropharyngeal cancers in Flanders (Belgium): a multicenter study.

Van Limbergen EJ, Dok R, Laenen A, Hauben E, Van den Weyngaert D, Voordeckers M, De Neve W, Duprez F, Nuyts S.

B-ENT. 2014;10(1):7-14.

PMID:
24765823
36.

Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.

Olteanu LA, Berwouts D, Madani I, De Gersem W, Vercauteren T, Duprez F, De Neve W.

Radiother Oncol. 2014 Jun;111(3):348-53. doi: 10.1016/j.radonc.2014.02.017. Epub 2014 Apr 17.

PMID:
24746575
37.

Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.

Pottel L, Lycke M, Boterberg T, Pottel H, Goethals L, Duprez F, Van Den Noortgate N, De Neve W, Rottey S, Geldhof K, Buyse V, Kargar-Samani K, Ghekiere V, Debruyne PR.

Eur J Cancer Care (Engl). 2014 May;23(3):401-12. doi: 10.1111/ecc.12179. Epub 2014 Jan 28.

PMID:
24467393
38.

Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.

Nuyts S, Lambrecht M, Duprez F, Daisne JF, Van Gestel D, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W.

Radiother Oncol. 2013 Nov;109(2):323-9. doi: 10.1016/j.radonc.2013.06.044. Epub 2013 Aug 13.

PMID:
23953410
39.

Deformation field validation and inversion applied to adaptive radiation therapy.

Vercauteren T, De Gersem W, Olteanu LA, Madani I, Duprez F, Berwouts D, Speleers B, De Neve W.

Phys Med Biol. 2013 Aug 7;58(15):5269-86. doi: 10.1088/0031-9155/58/15/5269. Epub 2013 Jul 12.

PMID:
23852041
40.

Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.

Berwouts D, Olteanu LA, Duprez F, Vercauteren T, De Gersem W, De Neve W, Van de Wiele C, Madani I.

Radiother Oncol. 2013 Jun;107(3):310-6. doi: 10.1016/j.radonc.2013.04.002. Epub 2013 May 3.

PMID:
23647760
41.

A predictive model for dysphagia following IMRT for head and neck cancer: introduction of the EMLasso technique.

De Ruyck K, Duprez F, Werbrouck J, Sabbe N, Sofie de L, Boterberg T, Madani I, Thas O, Wilfried de N, Thierens H.

Radiother Oncol. 2013 Jun;107(3):295-9. doi: 10.1016/j.radonc.2013.03.021. Epub 2013 Apr 22.

PMID:
23618501
42.

Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer.

Duprez F, Madani I, De Potter B, Boterberg T, De Neve W.

Dysphagia. 2013 Sep;28(3):337-49. doi: 10.1007/s00455-013-9452-2. Epub 2013 Feb 22. Review.

PMID:
23429941
43.

Symptomatic bilateral choroidal metastasis from breast cancer as first clinical sign of advanced metastatic tumor disease 31 years after diagnosis.

Kestelyn PA, Libbrecht L, Duprez F, Cocquyt V, Van Aken E.

Bull Soc Belge Ophtalmol. 2012;(319):29-33.

PMID:
22550775
44.

IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.

Duprez F, Madani I, Morbée L, Bonte K, Deron P, Domján V, Boterberg T, De Gersem W, De Neve W.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):252-9. doi: 10.1016/j.ijrobp.2011.06.1977. Epub 2011 Oct 24.

PMID:
22027259
45.

Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.

Madani I, Duprez F, Boterberg T, Van de Wiele C, Bonte K, Deron P, De Gersem W, Coghe M, De Neve W.

Radiother Oncol. 2011 Dec;101(3):351-5. doi: 10.1016/j.radonc.2011.06.020.

PMID:
21742392
46.

Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.

Deron P, Mertens K, Goethals I, Rottey S, Duprez F, De Neve W, Vermeersch H, Van de Wiele C.

Nuklearmedizin. 2011;50(4):141-6. doi: 10.3413/Nukmed-0367-10-11. Epub 2011 May 19.

PMID:
21594304
47.

Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.

Werbrouck J, Duprez F, De Neve W, Thierens H.

Int J Radiat Biol. 2011 Jan;87(1):46-56. doi: 10.3109/09553002.2010.518213.

PMID:
21142613
48.

Adaptive dose painting by numbers for head-and-neck cancer.

Duprez F, De Neve W, De Gersem W, Coghe M, Madani I.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1045-55. doi: 10.1016/j.ijrobp.2010.03.028. Epub 2010 Jul 17.

PMID:
20643512
49.

Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.

Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Madani I.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):450-8. doi: 10.1016/j.ijrobp.2009.10.028. Epub 2010 Apr 8.

PMID:
20381266
50.

Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.

Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, De Gersem W, De Neve W.

Radiother Oncol. 2009 Dec;93(3):563-9. doi: 10.1016/j.radonc.2009.10.012. Epub 2009 Nov 16.

PMID:
19919885

Supplemental Content

Loading ...
Support Center